StockNews.com began coverage on shares of Mannatech (NASDAQ:MTEX – Free Report) in a research report report published on Thursday morning. The firm issued a buy rating on the stock.
Mannatech Trading Down 0.7 %
NASDAQ:MTEX opened at $8.01 on Thursday. The company’s 50 day moving average is $8.48 and its 200-day moving average is $8.69. The company has a quick ratio of 0.51, a current ratio of 1.07 and a debt-to-equity ratio of 0.09. Mannatech has a 12 month low of $7.50 and a 12 month high of $15.10. The firm has a market cap of $15.06 million, a price-to-earnings ratio of -6.67 and a beta of 1.18.
Mannatech (NASDAQ:MTEX – Get Free Report) last announced its earnings results on Thursday, March 28th. The company reported ($0.94) EPS for the quarter. The firm had revenue of $32.69 million during the quarter. Mannatech had a negative return on equity of 19.19% and a negative net margin of 1.70%.
About Mannatech
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Further Reading
- Five stocks we like better than Mannatech
- Market Cap Calculator: How to Calculate Market Cap
- MarketBeat Week in Review – 4/29 – 5/3
- What is Insider Trading? What You Can Learn from Insider Trading
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- What is a SEC Filing?
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
